Metformin/pioglitazone [Competact] has been launched in the UK by Takeda for the treatment of type 2 diabetes mellitus

Source: Inpharma, Volume 1, Number 1559, 2006-10-14 , pp. 22-22(1)

Publisher: Adis International

Keywords: Development-status; Metformin/pioglitazone, therapeutic use; Product-launches; Research-and-development; Type-2-diabetes-mellitus, treatment

Document Type: Short communication

Publication date: 2006-01-01

• In this: publication
• By this: publisher
• In this Subject: Pharmacology

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers